GlassScriptPhysician profile
Shannon West
NPI 1982606794
$2,937.15
in general payments reported to CMS, 2019-2025
24 companies · $274 in 2025
The $274 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $110 · 2021: $1,168 · 2022: $136 · 2023: $654 · 2024: $486 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $821.82 | 2021 | |
| Ironshore Pharmaceuticals INC. | $344.08 | 2019-2024 | Jornay Pm |
| Corium, LLC | $274.32 | 2022-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $200.13 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $159.41 | 2024 | Qelbree |
| Tris Pharma INC | $156.67 | 2019-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $146.24 | 2019-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Pfizer INC. | $121.82 | 2021-2025 | |
| Cranial Technologies, INC | $102.16 | 2019-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $99.08 | 2025 | Jornay Pm |
| Phadia US INC. | $74.95 | 2020-2024 | Immunocap |
| Glaxosmithkline, LLC. | $64.27 | 2021-2024 | Bexsero |
| Cognoa, INC. | $57.40 | 2023 | Canvas Dx |
| Alk-Abello, INC | $52.20 | 2025 | Odactra, Grastek, Ragwitek |
| Adlon Therapeutics L.P. | $45.77 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $37.58 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $33.73 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $28.28 | 2024 | Daybue |
| Kowa Pharmaceuticals America, INC. | $24.54 | 2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $22.30 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $19.29 | 2024 | Kristalose |
| Ars Pharmaceuticals Operations, INC. | $18.52 | 2025 | Neffy |
| Seqirus USA INC | $17.35 | 2025 | Flucelvax |
| Shire North American Group INC | $15.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.